CBA Annual Conference, Saturday, Oct. 29, 2011
Topic: “The World is Flat: Glocalization of Biotech or Biopharma Industry”
Distinguished Speakers:
• Dr. Howard Chang, Associate Professor at Stanford University
• Mr. James Chapman, Partner at Foley and Lardner, LLP
• Dr. Wei-Kuang Chi, VP, Development Center for Biotechnology in Taiwan
• Mr. Ethan Knowlden, VP at Novartis Diagnostics
• Dr. Jim Larrick, Managing Director of Panorama Research Institute
• Dr. John Lin, Executive Director at Pfizer
• Dr. Tue Nguyen, VP at One World Health
• Dr. Wenjun Ouyang, Senior Scientist at Genentech
• Dr. Rose Romeo , Senior Director at Hunter Laboratories, Inc.
• Dr. Youe-Kong Shue, President and CEO of Optimer Biotechnology, Inc.
• Dr. Yuker Wang, Director at Affymetrix
• Dr. Guoliang Yu, CEO of Epitomics
• Dr. Wei Kuang Chi, VP of Development Center for Biotechnology, Taiwan
Date and Time: Saturday, October 29, 2011; 9:00 AM - 7:00 PM
Location: Li Ka Shing Learning & Knowledge Center (LKSC), 291 Campus Drive, Stanford, CA 94305 (LKSC Direction:http://bit.ly/oM8JHq Parking Direction: http://bit.ly/rhgUj4 )
See details at www.cbasf.org
Price:$. Members & Students: Free
Non-Member: $20
Lunch Buffet Evening Reception: FREE for all attendees
Parking: Free
Website:http://bit.ly/rb6b4U
Email:rsvp@cbasf.org
Topics:
1. Breakthrough Monoclonal Antibody Technology
2. Novel Antibody Drugs for Autoimmune and Age-Related Diseases.
3. New Technologies for Clinical Diagnostics in Tumor Samples and at A Single Cell Level.
4. Business Opportunities and Challenges Between US and China.
5. How Does Globalization of the Biopharma Industry Mean for Bay Area Entrepreneurs?
